SCHEMBL3775361

SCHEMBL3775361

O=S(CCCl)OS(=O)CCCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11531478 0.75
SCHEMBL11221834 0.75
SCHEMBL11230328 0.73
SCHEMBL11533749 0.71
SCHEMBL11223505 0.69
SCHEMBL11227521 0.69
SCHEMBL11531119 0.68
SCHEMBL11227086 0.66
SCHEMBL11528276 0.66
SCHEMBL11530458 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116942890-B Antibacterial anti-inflammatory thermosensitive hydrogel with function of promoting wound closure and preparation method thereof 西南交通大学 2024-04-02 CN disclosed
CN-116942890-A Antibacterial anti-inflammatory thermosensitive hydrogel with function of promoting wound closure and preparation method thereof 西南交通大学 2023-10-27 CN disclosed
US-20100316712-A1 PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF PARKINSON'S DISEASE AND RELATED DISORDERS COMBINATORX, INCORPORATED (US) 2010-12-16 US disclosed
EP-2063867-A2 PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF PARKINSON'S DISEASE AND RELATED DISORDERS Combinatorx, Incorporated (US) 2009-06-03 EP disclosed
US-20080299204-A1 Dosage forms for movement disorder treatment SPHERICS, INC. (US) 2008-12-04 US disclosed
WO-2008079404-A2 PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF PARKINSON'S DISEASE AND RELATED DISORDERS COMBINATORX, INCORPORATED (US) 2008-07-03 WO disclosed
US-20080131492-A1 Dosage forms for movement disorder treatment SPHERICS, INC. (US) 2008-06-05 US disclosed
WO-2008002471-A2 EROSION-STABILIZED BIOADHESIVE POLYMERS FUNCTIONALIZED OR BLENDED WITH CATECHOL AND DERIVATIVES THEREOF SPHERICS, INC. (US) 2008-01-03 WO disclosed
US-20070148238-A1 Dosage forms for movement disorder treatment SPHERICS, INC. (US) 2007-06-28 US disclosed
WO-2007002318-A2 BIOADHESIVE POLYMERS SPHERICS, INC. (US) 2007-01-04 WO disclosed
US-20070003621-A1 Dosage forms for movement disorder treatment SPHERICS, INC. (US) 2007-01-04 US disclosed